Journal of Inherited Metabolic Disease

, Volume 35, Issue 6, pp 1071–1079

Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series

  • Anke Thümler
  • Elke Miebach
  • Christina Lampe
  • Susanne Pitz
  • Wolfgang Kamin
  • Christoph Kampmann
  • Bianca Link
  • Eugen Mengel
Original Article

DOI: 10.1007/s10545-012-9474-1

Cite this article as:
Thümler, A., Miebach, E., Lampe, C. et al. J Inherit Metab Dis (2012) 35: 1071. doi:10.1007/s10545-012-9474-1

Abstract

Objective

To assess clinical features and general health status of adult patients with mucopolysaccharidosis (MPS) VI.

Methods

This report includes the clinical history of patients older than 18 years with slowly progressing MPS VI and the retrospective analysis of the outcomes of available data collected between September 2003 and October 2008 at the Center of Pediatric and Adolescent Medicine, University Medical Center, Johannes Gutenberg-University of Mainz, Germany. Variables included were urinary glycosaminoglycan (uGAG) level, mutation analysis, body height, forced vital capacity (FVC), 6-minute walk test, echocardiographic findings, the need for craniocervical decompression surgery, orthopaedic findings and ophthalmological assessments.

Results

The analysis included nine patients with MPS VI aged 19-29 years. The median age at diagnosis was 12 (range 6–20) years. At the time of the assessment (median age 25 years), median uGAG was 29 (range 15-149) μg/mg creatinine and median height 152 (range 136–161) cm. All patients had a FVC below standard values, seven showed reduced endurance in the 6-minute-walk test, all had valve changes with valve replacement in three, two underwent craniocervical decompression surgery, two underwent carpal tunnel surgery, five had ear/nose/throat (ENT) interventions, seven had hip pain/dysplasia, seven had corneal clouding and two were visually impaired.

Conclusions

Although patients with slowly progressing MPS VI are a heterogeneous group showing disease manifestations in several organs, they seem to have some typical characteristics in common. Despite the attenuated clinical course, many of these patients show severe morbidity. Therefore, early diagnosis and proper follow-up and treatment are essential.

Copyright information

© SSIEM and Springer 2012

Authors and Affiliations

  • Anke Thümler
    • 1
  • Elke Miebach
    • 2
  • Christina Lampe
    • 2
  • Susanne Pitz
    • 3
  • Wolfgang Kamin
    • 4
  • Christoph Kampmann
    • 5
  • Bianca Link
    • 6
  • Eugen Mengel
    • 2
    • 7
  1. 1.Department of PsychiatryUniversity of MainzMainzGermany
  2. 2.Villa Metabolica, Center of Pediatric and Adolescent MedicineUniversity Medical Center, Johannes Gutenberg-University of MainzMainzGermany
  3. 3.Department of OphthalmologyUniversity Medical Center, Johannes Gutenberg-University of MainzMainzGermany
  4. 4.Children’s Hospital Evangelisches Krankenhaus HammHammGermany
  5. 5.Department of Cardiology, Center of Pediatric and Adolescent MedicineUniversity Medical Center, Johannes Gutenberg-University of MainzMainzGermany
  6. 6.Division of Metabolism, Connective Tissue UnitUniversity Children’s HospitalZurichSwitzerland
  7. 7.Department of PediatricsMainzGermany